Type of Cancer
Breast Oncology
Phase
Division (Location)
Study ID
NCT#
Brief Description
PALLAS: PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for hormone receptor positive (HR+) / human epidermal growth factor receptor 2 (HER2)-negative early breast cancer
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.